The results suggested that RREs may inhibit the proliferation and apoptosis of HCC cells by inducing ROS production, decreasing Bcl-2/Bax ratio, and significantly decreasing mitochondrial membrane potential of HepG2 cells, thus inhibiting the progression of HCC. The gene discussed is BAX; the disease is hepatocellular carcinoma.